Related by context. All words. (Click for frequent words.) 73 HDL Therapy 71 platform HDL Mimetic 69 Initiates Enrollment 68 Presents Preclinical Data 68 Receives Orphan Drug Designation 68 Initiates Clinical Trial 68 Initiates Phase II 67 FOLOTYN ® 66 Kinase Inhibitor 66 Nuclear Receptors 66 Initiates Clinical 66 Personalized Immunotherapy 66 JAK2 Inhibitor 66 targeted antifolate 66 molecular imaging radiopharmaceutical 65 OTCBB PYTO 65 OTCBB HXBM developer 65 HDL Mimetic Peptide 65 highly selective inhibitor 65 Reports Preclinical Data 65 Small Molecule 65 samarium Sm 65 Intravenous Human 64 Tezampanel 64 SPL# Gel vaginal microbicide 64 Therapeutic Competitors companiesandmarkets.com adEgemonye 64 lexidronam injection 64 acetonide FA 64 Phase 2b Clinical Trial 64 OTCBB CVBT 64 Phase Ib Clinical Trial 64 Squalamine 64 Novel Oral 64 Regenerative Cells 64 AAG geldanamycin analog 64 Systemic Delivery 64 humanized anti 64 pralatrexate injection folate analogue 64 ARRY # 64 Initiate Clinical Trial 64 Epeius Biotechnologies Corporation 63 TRANSDUR ™ 63 selective kinase inhibitor 63 Begins Dosing 63 AMEX RGN 63 Presents Preclinical 63 targeted radiotherapeutic 63 OTCBB HNAB 63 Inc. OTCBB OXIS 63 ArQule Kinase Inhibitor Platform 63 ALN PCS 63 humanized monoclonal 63 HuCAL GOLD R 63 DNA intercalator 63 Surgical Sealant 63 Potelligent Technology 63 Successfully Completes Phase 63 FDA APPROVES 63 injectable bulking agent 63 Announces Poster Presentations 63 mitogen activated ERK kinase 63 investigational humanized monoclonal antibody 63 Initiates Phase III 63 Inc. Nasdaq IMGN 63 EnteroMedics proprietary neuroblocking technology 63 candidate deforolimus 63 Marillion Pharmaceuticals 63 Immunotherapeutic 63 Oral Mucositis 63 Phase #b/#a clinical 63 vapreotide acetate 62 Breast Cancer Assay 62 REGENERX BIOPHARMACEUTICALS INC. 62 Fc fusion protein 62 VitiGam 62 NasdaqGM NTEC today 62 MP4 molecule 62 Demonstrates Significant 62 Develops Novel 62 Nasdaq HALO biopharmaceutical 62 product platforms AZX# 62 Lexicon Genetics Incorporated 62 mertansine 62 hyaluronidase enzyme 62 topically applied SEPA 62 COX Inhibiting Nitric Oxide 62 ALN HPN 62 Abstract Accepted 62 Shai Novik President 62 EGIR 62 BioSepra 62 Anti Tumor 62 NASDAQ CRXL 62 ELADUR TM 62 sapropterin dihydrochloride 62 ZEVALIN ® 62 Receives Approvable Letter 62 Genotyping Test 62 modulator SERM 62 Preclinical Study 62 NYSE Amex PBTH 62 2 methoxyestradiol 62 Locked Nucleic Acid 62 include PLX IBD 62 non nucleoside inhibitor 62 Drug Candidate 62 ALTROPANE R 62 CancerVax Corporation 62 patented Bioral 61 targeting CD# 61 selective immunoproteasome inhibitor 61 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 61 Biomarker Study 61 novel peptide 61 Phase III Clinical Trial 61 PROSTASCINT R 61 Nabi HB ® 61 anti infective treatments 61 Wafer polifeprosan 61 selective estrogen receptor modulator 61 RNAi Therapeutic 61 documented candidiasis 61 5 HT3 antagonist 61 pan HDAC inhibitor 61 Phase 2a Clinical Trial 61 Genaera Corporation 61 sarcoma melanoma 61 AMEX REX 61 Initiates Dosing 61 tiapamil 61 adult mesenchymal stem 61 urethral bulking agent 61 Idera Pharmaceuticals 61 HuMax HepC TM 61 CRMD# 61 endoluminal stent graft 61 Liprotamase 61 OTCBB NPHC 61 Emollient Foam 61 peptide conjugated 61 RECOTHROM R 61 oral prodrug 61 Factor VIIa 61 CYT# potent vascular disrupting 61 QUADRAMET R 61 DermTech International 61 Gets FDA Clearance 61 Alternext ALEHT 61 lucinactant 61 vaccine GRNVAC1 61 JAK1 61 Optical Biopsy System 61 Panzem R 61 Akebia Therapeutics 61 PDE4 inhibitor 61 IL# PE#QQR 61 Nasdaq HALO 61 kidney urologic 61 Eluting Coronary Stent System 61 BUPHENYL R 61 OTCBB CHKT 61 Phase 2b Trial 61 Bazedoxifene 61 OTCBB IMNR 61 ALN TTR 61 treating abdominal aortic 61 SMARTICLES ® 61 tkRNAi 61 NYSE AMEX IBIO 61 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 61 Initiates Phase 2b 61 Adult Stem Cell Therapy 60 R roscovitine 60 Pafuramidine 60 Locked Nucleic Acid LNA 60 Friedreich Ataxia FRDA 60 MET VEGFR2 60 OTCBB PYTO FWB ET6 60 protein tyrosine phosphatase 1B 60 Homspera TM 60 Protease Inhibitor 60 Therapeutic Vaccine 60 novel peptides 60 fosbretabulin 60 Schisandrin B 60 Cleviprex TM clevidipine 60 Arno Therapeutics 60 novel histone deacetylase 60 HDAC Inhibitor 60 OTCBB CTIX 60 CCR9 antagonist 60 coronary stent merged 60 POTELLIGENT ® 60 NASDAQ LGND 60 KL4 Surfactant 60 Microspheres 60 TLK# 60 Monoclonal Antibody 60 oral beclomethasone dipropionate 60 derivatives Radilex TM 60 PDX pralatrexate 60 anticancer compound 60 rxRNA 60 IAP inhibitor 60 Bepreve TM 60 HDL Selective Delipidation 60 Microsphere 60 PNP inhibitor 60 Angiocept 60 Inc. Nasdaq ALNY 60 Nasdaq DVAX 60 Parathyroid Hormone 60 SagaX 60 3 kinase PI3K 60 ELADUR ™ 60 Ichor Medical Systems 60 Transfection 60 Marqibo TM 60 Selective Electrochemical Tumor Ablation 60 Aplidin R 60 ALN TTR# 60 nasal decolonization 60 FGFR 60 Degarelix 60 IgG1 monoclonal antibody 60 antisense inhibitors 60 Gamma secretase 60 candidates Azedra TM 60 TELINTRA R 60 Creabilis Therapeutics 60 Pyridorin 60 multi kinase inhibitor 60 Epidermal Growth Factor Receptor 60 VIVITROL ® 60 Replacement Therapy 60 Cetrorelix 60 Activity Assay 60 RNAi therapeutic targeting 60 Gonal f R 60 Adrian Hobden Ph.D. 60 Recombinant Human 60 First Patient Treated 60 NanoTab 60 commercializing anti infective 60 Ecallantide 60 Metabolic Disease 60 NeutroPhase TM 60 Vion Pharmaceuticals 60 oral probiotic 60 myelofibrosis polycythemia vera 59 CEQ# 59 CAPHOSOL R 59 PHX# 59 Nasdaq ACHN 59 Neurome 59 Helinx technology 59 AMPA kainate 59 Nasdaq OMER 59 PKC# 59 ThermoDox ® clinical 59 Zemiva TM 59 Submits Response 59 Antithrombin 59 Evoclin R 59 mediated inhibition 59 Metastatic Melanoma 59 receptor partial agonist 59 Transdermal Delivery 59 mTOR mammalian target 59 Oral Spray 59 antibody MT# 59 TSX VENTURE SVA 59 Prodarsan R 59 Tumour Vascular Disrupting Agent 59 developing TB4 59 NDA Submission 59 Biosensor System 59 DURECT proprietary 59 bevacizumab Avastin ® 59 M2 subunit 59 Gastrointestinal Liner 59 Familial Adenomatous Polyposis FAP 59 Initiate Phase 59 isoform selective 59 ERYtech 59 brivanib 59 Pivotal Phase III 59 telomerase inhibitor drug 59 PF # [002] 59 selective antagonist 59 KL4 surfactant 59 Lubiprostone 59 methylnaltrexone bromide 59 Antimicrobial Coating 59 StromaCel Inc. 59 VISICOL R 59 MOVIPREP R 59 catheter occlusion 59 Avicena 59 Polymer Microspheres 59 Receives SFDA Approval 59 Orally administered 59 Adagen ® 59 Lyophilized 59 Genasense ® oblimersen 59 Pulmonary Arterial Hypertension 59 coronary vasodilation 59 Fondaparinux 59 histamine dihydrochloride 59 P#Y# [001] 59 OTCBB INSV 59 Regado Biosciences 59 anti CD3 59 Quark Biotech Inc. 59 histone deacetylase HDAC inhibitor 59 AMEX DDD 59 Aurora Kinase 59 markets HP Acthar 59 Ad5FGF 4 59 VisEn Medical 59 Nasdaq VRTX today 59 ProEthic Pharmaceuticals 59 Nasdaq IDRA 59 selective inhibition 59 ADP receptor antagonist 59 BioSante Pharmaceuticals Announces 59 P#X# antagonist 59 Thrombin topical Recombinant 59 PROGENSA R 59 LibiGel ® 59 compound perifosine 59 Guanilib 59 Intravascular 59 HepaSphere 59 polysaccharide polymer 59 pharma.com 59 Romiplostim 59 BioSET 59 mGluR2 NAM 59 Aradigm Corporation 59 VivaGel ™ 59 Bucindolol 59 Mucosal 59 topical non steroidal 59 PORxin TM 59 vinorelbine tartrate 59 Methylnaltrexone 59 immune modulatory 59 Receives CE Marking 59 Thiarabine 59 Vaccine Adjuvant 59 PRT# 59 PFIZER INC. 59 Crit Rev 59 Fibroblast Growth Factor Receptor 59 telomerase therapeutic 59 Calcitonin 59 DUROS 58 anti amnesic 58 liver resection surgeries 58 rHuPH# recombinant human 58 monoclonal antibody mAb 58 phosphate receptor modulators 58 Pivotal Trial 58 leukotriene pathway 58 Myocet 58 seliciclib CYC# 58 Contrast Enhanced 58 AFREZZA TM 58 rALLy clinical trial 58 Inc. OTCBB ALRX 58 Inhalation Solution 58 Investigational Compound 58 oral picoplatin 58 ENTB 58 FS Antihemophilic Factor Recombinant 58 histone deacetylase inhibitor 58 POSIDUR TM ELADUR TM 58 NurOwn 58 NeuroSTAT ® 58 Valortim TM 58 hormone agonist 58 acadesine 58 subsidiary Cira Biosciences 58 Reverse Cholesterol Transport 58 external counterpulsation systems 58 FUSILEV ® 58 TSX CTI 58 Delivery System NTDDS 58 PI3 kinase inhibitors 58 Luteinizing Hormone Releasing Hormone 58 Aloxi ® 58 Aganocide ® 58 Silodosin 58 muco adhesive technology 58 A2 Lp PLA2 58 SinuNase ™ 58 FDA Approvals 58 Fibrocell Science 58 Chemokine Receptor 58 migraines neurorehabilitation 58 Nasdaq CGEN 58 AzaSite Xtra 58 NASDAQ NRGN 58 sodium thiosulfate STS 58 Curaxin CBLC# 58 AMEX KAL 58 Amira Pharmaceuticals 58 beta 1a 58 TRO# 58 commercializing therapeutic 58 ARCHITECT HIV 58 AUDIO PROVIDED BY 58 Nasdaq IDRA today 58 Biodesix 58 ORADUR ® 58 MelaFind R 58 RECOTHROM ® 58 ImmuKnow R 58 Kinase Inhibitors 58 OTCQB CTIX 58 Allogeneic 58 Adenosine Therapeutics 58 POTELLIGENT R 58 HuMax TAC 58 AQUA ® 58 Inhibitor Human 58 Fresenius Biotech 58 treat lupus renal 58 include Altastaph TM 58 personalized cellular immunotherapy 58 Cardioxyl Pharmaceuticals 58 EPIX Pharmaceuticals Inc. 58 intranasal formulation 58 Trandolapril 58 Collaborators Publish 58 Alligator Bioscience AB 58 Safinamide 58 Solazed ™ 58 Xcytrin R 58 inhibit oxidative stress 58 P#X# 58 hypervascular tumors 58 NasdaqGM SPPI 58 pathophysiological effects 58 miRagen Therapeutics 58 orally bioavailable mimics 58 reslizumab 58 Trodusquemine 58 OMP #R# 58 Anavex #-# 58 #:#-# [023] 58 Clearant Inc. 58 Vascular Grafts 58 Hematopoietic 58 NASDAQ FLML 58 CINtec R 58 Nasdaq RXII 58 TAFA# 58 Vascugel 58 fibrotic disorders 58 Clinical Outcome 58 GRAS Status 58 specific lectin receptors 58 developing Zerenex ferric 58 Onalta TM 58 Vidaza R 58 prokinetic agent 58 Zysolin TM 58 Submits Application 58 oral ghrelin agonist 58 Nektar PEGylation technology 58 Ultrasonic Wound 58 potently inhibit 58 Vascular Wrap TM 58 Cumulase 58 Zorbtive TM 58 candidates Azedra 58 Endotis 58 Orphan Drug designations 58 Virtual Histology 58 Trofex TM 58 BiovaxID TM 58 TLR9 agonist 58 Inc. NASDAQ IDMI 58 EGFR HER2 58 overactive bladder VANTAS R 58 Senesco Technologies 58 Nasdaq NRGN 58 Onko Sure TM 58 Nereus Pharmaceuticals 58 Skin Cholesterol Test 58 NASDAQ ALTH biopharmaceutical 58 CytoSorb TM 58 NUEDEXTA ™ 58 Ceflatonin R 58 Aegis Therapeutics 58 Inc. OTC MTBR 58 PCRX 58 compound AEZS 58 Milestone Payments 58 Angiolix 58 epoetin zeta 58 SCIB1 58 depsipeptide 58 HuMax 58 dietary supplement formulated 58 diarrhea predominant irritable 58 theranostic 58 gastrointestinal disorders ATI 58 Aliskiren 58 neuronal nicotinic receptors NNRs 58 Valera Pharmaceuticals 58 adenosine A2A 58 Myolimus 58 Hepatitis C Virus HCV 58 Covalon Technologies Ltd. 58 Respiratory Viral Panel 58 anti CD3 monoclonal 58 EnVivo Pharmaceuticals 58 peripherally acting 58 INFeD ® 58 Anticancer Agent 58 selective adenosine 58 Lifevantage Corporation 58 SuperAntibody 58 CD# CEA 58 Intravesical 58 Quark Biotech 58 GVAX ® 58 VBLOC TM 57 visit http:/www.martek.com 57 COLAZAL R 57 Iluvien ® 57 Chemokine Therapeutics 57 Oxis International 57 nasal calcitonin product 57 Monoclonal antibody 57 REGiMMUNE 57 SAR# [002] 57 Dendritic Cells 57 EnVivo 57 Aganocide 57 toenail onychomycosis 57 Oracea TM 57 Hypoxia Inducible Factor 57 cMET 57 IMiDs ® compound 57 Gamunex C 57 Ophthotech 57 Oral Fluid 57 Cloretazine 57 engineered RAP peptides 57 hypoxia activated prodrug 57 NAVISTAR R 57 drug conjugate 57 TSX VENTURE COT 57 JZP 57 TSX VENTURE GAP 57 adecatumumab MT# 57 BXT # 57 therapeutic monoclonal antibody 57 Tiuxetan 57 Intarcia 57 Gonal f ® 57 antisense inhibitor 57 compound ISA# 57 Cytochrome P# 57 lead molecular radiotherapeutic 57 Protexia ® 57 systemic RNAi therapeutic 57 NASDAQ CXSP announced 57 Cellgate Inc. 57 Sufentanil 57 novel immunotherapies 57 miRview meso 57 Lipid Sciences Inc. 57 PI3K/Akt pathway inhibitor 57 Inflammatory Diseases 57 TH# [003] 57 EOS NASDAQ MELA 57 selective androgen receptor modulator 57 MicroTechnology Transfer mt2 Program 57 mda 7 57 R Saizen R 57 SUPPRELIN R LA 57 Pegloticase 57 Inc. NASDAQ ORXE 57 Elagolix 57 Tumor Angiogenesis 57 catalytic antioxidant compounds 57 Romidepsin 57 Teva Provides Update 57 YM AIM YMBA 57 Aldara ® 57 Exherin 57 MetaDrug TM 57 Inhalation Aerosol 57 virus HCV protease inhibitor 57 OTCBB DORB 57 small molecule Hedgehog 57 Nasdaq MNKD focused 57 molecular imaging radiopharmaceuticals 57 FoldRx Pharmaceuticals Inc. 57 PEG SN# 57 chemosaturation 57 InNexus Biotechnology 57 novel emulsion formulation 57 Nasdaq SNSS 57 PNT# 57 NYSE Amex PTN 57 oral salmon calcitonin 57 NASDAQ INGN 57 Protalex Inc. 57 ATIR 57 Novosom 57 Adaptive Radiation Therapy 57 LifeCell Corporation 57 small molecule defensin 57 photodynamic therapy PDT 57 Nasdaq NPSP 57 mGluR4 57 Novolimus 57 NASDAQ CLSN 57 TSX BSY 57 Annamycin 57 GATTEX TM 57 antifibrotic 57 manufactures minimally invasive 57 Cyclooxygenase Inhibiting Nitric Oxide 57 Captisol ® 57 poly ethylene glycol PEG 57 NASDAQ AVNR 57 Phase 1b clinical trials 57 intracellular uptake 57 targets Galectin receptors 57 Manja Bouman CEO 57 immunotherapeutic vaccine 57 Paris IPN Euronext 57 phosphatidylinositol 3 57 antiapoptotic 57 Soriatane R 57 Randomized Clinical Trial 57 Nasdaq GENR 57 potent antiproliferative 57 immune modulation 57 biologic therapeutics 57 selective modulator 57 Oxytrol R 57 herpetic keratitis 57 thetreatment 57 Bioheart Inc. 57 Anidulafungin 57 Rhucin ® recombinant 57 Xenazine ® 57 vivo fluorescence imaging 57 Clinical Study Shows 57 thalidomide Thalomid 57 Phase IIb III 57 IMiDs R 57 Varespladib 57 candesartan cilexetil 57 NASDAQ OSIR 57 Bafetinib 57 FluoroPharma 57 Cethrin R 57 Panzem ® 57 EZN 57 Epiphany Biosciences 57 Phase IIb clinical trials 57 Tigecycline 57 Immunicon Corporation 57 HepDirect prodrug 57 HSP# inhibitor 57 Surgical Mesh 57 Pyridorin TM 57 AcuFocus 57 DP VPA 57 Azacitidine 57 Peyronie disease Frozen Shoulder 57 Soliris eculizumab 57 BLP# Liposome Vaccine 57 Saforis 57 NASDAQ EPIX 57 arsenic trioxide injection 57 OTCBB NRGX 57 somatostatin analog 57 novel therapeutic antibodies 57 Progenitor Cell 57 Cand5 56 EndoBarrier ™ 56 NASDAQ ENMD 56 5 HT4 56 DELATESTRYL R 56 Qutenza TM 56 small molecule activator 56 HuCAL ® 56 PSMA ADC 56 alpha#beta# 56 novel anti infective 56 Cypher Sirolimus 56 Expression PACE 56 MCSP respectively 56 vidofludimus 56 liposomal delivery 56 LHRH antagonist 56 glucagon receptor 56 Brussels THR 56 Taligen Therapeutics 56 EP #R 56 deCODE chemistry 56 Aphton Corporation 56 recombinant biopharmaceutical 56 DuNE 56 HyACT 56 LungExpress Dx TM 56 MWG Biotech 56 Supernus Pharmaceuticals 56 Myocardial Perfusion Imaging 56 Imagenetix Inc. 56 investigational pharmacologically unique 56 intravesical infusion therapy 56 BRANFORD Conn. BUSINESS WIRE 56 vaginally administered lidocaine 56 inhibitor RG# 56 Vascular Closure Device 56 OTCBB AOLS 56 Onconase 56 Affymetrix GeneChip ® 56 EVIZON TM 56 small molecule agonists 56 Stanate R 56 Nasdaq ENMD 56 bio.com 56 cathepsin K inhibitor 56 Ostabolin C TM 56 Restoraderm 56 Dalbavancin 56 dasatinib Sprycel 56 Applied Biosystems TaqMan 56 IAP inhibitors 56 iBio Inc. 56 DispersinB ® 56 NYSE Amex RGN 56 inhibitor SNRI 56 Analyte 56 ACAPODENE R 56 product Fentanyl TAIFUN 56 Cenomed 56 Anticancer Drug 56 volociximab 56 Resurgex Plus R 56 histone deacetylase HDAC 56 Electroporation 56 XOPENEX R 56 Novel Mechanism 56 Medistem Laboratories 56 treat benign prostatic 56 systemic immunosuppressive drugs 56 GeneThera Inc. 56 Nasdaq ENZN 56 receptor tyrosine kinase inhibitor 56 nucleotide analog 56 ProMune 56 t2cure GmbH 56 Ceragenix Pharmaceuticals 56 ERYtech Pharma 56 tiuxetan 56 rhMBL 56 huC# DM4 56 Ranolazine 56 Olmesartan 56 betamethasone dipropionate #.# 56 peroxisome proliferator activated 56 cleavable linker 56 vivo validation 56 Optical Coherence Tomography 56 radiotherapeutic 56 FzioMed 56 GW# [003] 56 novel orally administered 56 Electronic Brachytherapy System 56 JAK Inhibitor 56 polycythemia vera PV 56 NovaBay Aganocide compounds 56 ThermoDox R 56 Investigational eFlow Nebulizer System 56 Biosign Technologies Inc. 56 MGd 56 PRNewswire FirstCall YM BioSciences 56 COMPLEGENT TM Technologies 56 Eurand Pharmaceuticals 56 Cathepsin S 56 NADiA 56 AMEX ISV 56 ATL# [001] 56 Inc. NASDAQ AEZS 56 Pediatric Oncology Branch 56 wilate ® 56 zanolimumab 56 Deferiprone 56 ZYBRESTAT TM 56 sorafenib Nexavar 56 Neuroprotection 56 RNAi therapeutic targeting PCSK9 56 ALVESCO ® 56 therapeutic monoclonal antibodies 56 EXPAREL TM 56 chronic eosinophilic leukemia 56 Percutaneous Tibial Nerve Stimulation 56 DIFICID ™ 56 Resurgex Plus 56 rasagiline tablets 56 ProAlgaZyme R 56 Hedgehog Pathway Inhibitor 56 reversible inhibitors 56 AEG# 56 IMPACS R 56 Percutaneous Transluminal Coronary Angioplasty 56 Novasome R 56 EnzymeRx 56 Enhanze 56 InnerCool Therapies 56 Biotherapeutic 56 FASEB J. 56 Dabigatran etexilate 56 imatinib Gleevec ® 56 Wound Dressing 56 oral Janus kinase 56 EnteroMedics proprietary neuroblocking 56 sodium Injection 56 Intradermal 56 Inc. OTCBB SYBD 56 Hsp# inhibition 56 Nasdaq SCLN 56 TSX SHQ 56 SyntheMed Inc. 56 mechanical thrombectomy 56 induces apoptosis 56 Goserelin 56 Zenvia ™ 56 Alinia 56 diagnostic radiopharmaceutical 56 aerosolized AAT 56 Emezine 56 apricitabine ATC 56 Spinal Elements 56 intravenous AAT 56 proteasome inhibitor 56 A3 adenosine receptor 56 Angiox ® 56 OTC IPXL today 56 Insegia 56 IMiD 56 cyclin dependent kinase inhibitor 56 PGL# 56 MAGE A3 ASCI 56 MEK inhibitor 56 ENZON 56 OSI Prosidion 56 5 HT2A inverse 56 radiation sensitizer 56 pigmentary disorders 56 hyperphosphorylation 56 Arbios Systems Inc. 56 Phase III multicenter 56 hypoxia inducible factor 56 phosphate S1P 56 agent bevasiranib 56 Nasdaq OMER biopharmaceutical 56 Modrenal R 56 Factor Xa inhibitor 55 treat chronic sinusitis 55 hypereosinophilic syndrome 55 molecular diagnostic assay 55 NIC5 55 Diabetic Neuropathy 55 aurora kinase 55 Phase Ib clinical 55 ZARS Pharma 55 DNA methylation biomarkers 55 Esmya 55 phosphoinositide 3 55 oxybutynin gel 55 MyVax R 55 Cannabinoid 55 Corixa Corporation 55 Sphingomab TM 55 BioElectronics Corporation Announces 55 #-# Full Text 55 Adnectin 55 molecular biomarkers 55 ddRNAi 55 Embolic Protection 55 AquaMed Technologies Inc. 55 Iloperidone 55 engineered proteases 55 Dermylex TM 55 Kineret ® 55 Omacetaxine 55 PCK# 55 Generx TM 55 Unigene nasal calcitonin 55 Ercole Biotech 55 investigational therapies 55 Receives Favorable 55 OTCBB CHKT biotechnology 55 cutaneous T 55 targeting PCSK9 55 OTCBB URGP specialty 55 SYCREST 55 PRNewswire FirstCall Neurogen 55 Bioral Amphotericin B 55 mesylate tablets 55 including eniluracil ADH 55 vascular disrupting agent 55 Nasdaq ACEL 55 Pathway Inhibitor 55 centromere associated protein 55 initiated Phase Ib 55 Neulasta R 55 Etubics 55 RhuDex ® 55 Allovectin 7 r 55 symptomatic benign prostatic 55 Predictive medicine 55 LNP formulations 55 Fluxion Biosciences 55 AKT inhibitor 55 Amphotericin B 55 Prochieve R 55 Photodisinfection System 55 Itraconazole 55 IRX 2 55 Targeted Chemotherapy 55 NASDAQ ACOR 55 AQ4N 55 Deforolimus 55 Aganocide TM 55 siRNA therapeutics 55 DosePro TM 55 Bioral Amphotericin B. 55 Xencor XmAb 55 Pervasis Therapeutics Inc. 55 Inc. PINKSHEETS MEDS 55 Crop BioScience 55 Proteo 55 FACTIVE ® 55 Intraosseous Infusion System 55 Cloretazine ® 55 QuadraSphere 55 FACTIVE R gemifloxacin 55 CardioVascular BioTherapeutics 55 Factor VEGF 55 alpha melanocyte stimulating 55 Cancer Vaccines 55 Dual Opioid TM 55 Androgen Receptor 55 InterfeRx 55 ONCASPAR 55 Dynabeads 55 Tecnis R 55 Diabetic Foot Ulcer 55 BY WILLA J. 55 Retinoic Acid 55 tubulin inhibitor 55 Injectable Suspension 55 RTP #i 55 Lumbar Interbody Fusion 55 Trophos 55 Vical Incorporated 55 molecular chaperone regulation 55 histone deacetylase HDAC inhibitors 55 Ore Pharmaceuticals 55 Solagé 55 abobotulinumtoxinA 55 Vidofludimus 55 DermTech 55 NASDAQ ENZN 55 HP Acthar Gel repository 55 Sanvar R 55 RenaZorb TM 55 Fludara ® 55 Catheter Associated 55 SCHERING PLOUGH 55 SAFLUTAN 55 Nasdaq HLCS 55 Adhesion Barrier 55 anticancer agent 55 Civacir 55 Panzem 55 Nanobody R 55 Novel Small Molecule 55 Zevalin R Ibritumomab 55 Chemokine 55 Cytokine PharmaSciences 55 Apaziquone 55 Gentamicin Surgical Implant 55 bioactive compound